4Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of u- terine leiomyomas: a review[ J]. Environ Health Perspect,2003, 111(8) : 1037-1054.
5Greathouse KL, Bredfeldt T, Everitt JI,et al. Environmental es- trogens differentially engage the histone methyhransferase EZH2 to increase risk of uterine tumorigenesis [ J]. Mol Caneer Res, 2012,10(4) :546-557.
6Walker CL. Epigenomic reprogramming of the developing repro- ductive tract and disease susceptibility in adulthood [ J ]. Birth Defects A Clin Mol Teratol,2011,91 (8) :666-671.
7Lee EJ, Kong G, Lee SH, et al. Profiling of differentially ex- pressed genes in human uterine leiomyomas [ J ]. Int J Gynecol Cancer,2005,15 ( 1 ) : 146-154.
8Hsieh YY, Chang CC,Tsai CH, et al. Interleukin (IL)-12 recep- tor betal codon 378 G homozygote and allele,but not IL-1 (beta- 511 promoter, 3953 exon 5, receptor antagonist) , IL-2 114, IL-4- 590 intron 3, IL-8 3 "-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma [ J ]. Fertil Steril,2007, 87(4) :886-895.
9Okolo S. Incidence, aetiology and epidemiology of uterine fibroids [ J]. Best Pract Res Clin Obstet Gynecol, 2008,22 (4):571- 588.
10Wang L, Huang H, Liu D, et al. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas[ J]. Gynecol Endocri- nol,2012,28 (8) :665-668.
